Fig. 1

Changes in serum sCD26 levels following YS110 administration by Box and Whisker plot analysis. Each plot indicated the serum sCD26 titer variation from baseline (day 1pre, 100%) to pre/post of YS110 administration on days 1, 15 and 29. Analyzed data were stratified into a total 26 cases, b 18 cases with Q2W administration, c 14 male cases with Q2W administration, d 8 cases with Q1W administration, e 19 MM cases, f 12 MM cases with Q2W administration, g 9 MM, male cases with Q2W administration, h 6 RCC cases. Data are shown as mean ± S.D. in each group